Protein Kinase C 19-31 (Synonyms: PKC (19-31)) |
Catalog No.GC37014 |
La protéine kinase C 19-31, un peptide inhibiteur de la protéine kinase C (PKC), dérivée du domaine régulateur pseudo-substrat de la PKCa (résidus 19-31) avec une sérine en position 25 remplaçant l'alanine de type sauvage, est utilisée comme peptide substrat de la protéine kinase C pour tester l'activité de la protéine kinase C.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 121545-65-1
Sample solution is provided at 25 µL, 10mM.
Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity. Protein kinase C (PKC) is involved in controlling the function of other proteins through the phosphorylation of hydroxyl groups of serine and threonine amino acid residues on these proteins[1][2].
[1]. Mellor H, et al. The extended protein kinase C superfamily. Biochem J. 1998 Jun 1;332 ( Pt 2):281-92. [2]. Nishizuka Y (1995). Protein kinase C and lipid signaling for sustained cellular responses" (abstract). FASEB J. 9 (7): 484-96.
Average Rating: 5
(Based on Reviews and 14 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *